MDR (Medical Device Regulation)

MDR (Medical Device Regulation) - Axcellant

MDR (Medical Device Regulation)

  1. lut 28, 2025

What Does the 'MDR (Medical Device Regulation)’ Mean?

MDR stands for Medical Device Regulation, which is a set of rules and requirements governing the production and distribution of medical devices in the European Union. It was implemented to ensure the safety and efficacy of medical devices, replacing the previous Medical Devices Directive (MDD).

The MDR establishes a robust, transparent, and sustainable regulatory framework for medical devices in the EU market. It introduces stricter pre-market control, post-market surveillance, and traceability requirements for manufacturers, while also enhancing the protection of public health and patient safety.

Why Is the 'MDR (Medical Device Regulation)’ Important in Clinical Research?

MDR is crucial in clinical research as it directly impacts the development, testing, and approval processes for medical devices in the European Union. It sets stringent standards for clinical evidence, requiring manufacturers to conduct more comprehensive clinical investigations and post-market clinical follow-up studies to demonstrate device safety and performance.

Understanding MDR is essential for researchers and sponsors involved in medical device trials within the EU. It influences study design, data collection methods, and reporting requirements, ensuring that clinical research aligns with regulatory expectations and facilitates smoother market access for new medical devices.

Good Practices and Procedures

  1. Implement a robust post-market surveillance system to continuously monitor device performance and safety in real-world settings, including systematic data collection and analysis.
  2. Establish a comprehensive risk management process that covers the entire lifecycle of the medical device, from design to obsolescence, with regular updates based on new data.
  3. Develop and maintain a detailed technical documentation file (Technical File) that includes all required elements, such as clinical evaluation reports and risk management documentation.
  4. Conduct thorough internal audits of quality management systems and processes to ensure ongoing compliance with MDR requirements and identify areas for improvement.
  5. Implement a structured process for evaluating and incorporating user feedback and complaints into product improvements and risk mitigation strategies.

Related Terms

Resources

Axcellant at ICNC Berlin: Following the Future of Nuclear Cardiology – and helping bring it to clinical reality

The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…

One trial is no longer enough. Regulators on both sides of the Atlantic are building a new model of clinical evidence

The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…